Wedbush’s Ives reiterates Outperform on SpaceX stock citing SI growth

Wedbush reiterated an Outperform rating and a $225 price target on SpaceX, citing nearly threefold sequential growth in SI revenue and a 65.5% segment adjusted EBITDA margin; companywide LTM EBITDA was $5.9 billion. SpaceX reported quarterly capex of $19.59 billion, and Wedbush sought more detail on cloud-sales backlog, capacity timing, Starship plans and debt financing; the article also notes the stock trades above InvestingPro’s estimated fair value and that analysts forecast profitability this year.

Analysis

The investable question is whether the cloud ramp can earn its way through a very large investment cycle—not whether analyst targets are rising. A reported segment margin is encouraging, but without backlog, conversion timing, and capex scope it does not establish consolidated free-cash-flow economics. If capacity arrives ahead of contracted demand, depreciation and financing costs could absorb the operating leverage; if demand is contracted and capacity-constrained, launch cadence becomes a revenue catalyst. Verify the cloud backlog and capex by business before extrapolating.

Near term, target dispersion is a sentiment signal, not valuation evidence. The broader increase in AI-linked borrowing and CDS activity raises the hurdle rate for capital-intensive growth stories, but does not by itself prove issuer-specific stress. Apollo’s reported financing role makes funding terms and structure worth monitoring; it is not evidence of a direct equity catalyst for Apollo.

Over 1–3 months, the key catalysts are disclosed contracted-cloud backlog, capacity delivery, and funding details. Over 6–18 months, Starship reliability and regulatory approvals could change launch economics, while the spectrum agreement is a later-dated option rather than near-term earnings. Oracle could face competitive pressure if customers substitute toward this cloud offering, but the article provides no evidence of customer churn; NVIDIA’s exposure is more indirect through AI infrastructure demand. Contrarian view: the bullish narrative may price in successful execution before backlog quality and cash returns are demonstrated. The thesis improves with backlog conversion and credible funding; it weakens if guidance slips, capex expands without contracted utilization, or financing costs rise.

Key Decisions for Investors

• Do not chase SPCX solely on analyst target increases. For existing exposure, consider a modest hedge or trim until backlog, capacity timing, and funding terms are disclosed; option liquidity and pricing should be checked before using puts.
• Set a 1–3 month alert for cloud backlog/conversion disclosure and capex scope. Reassess positively if contracted demand is keeping pace with capacity; cut risk if delivery timelines slip or investment rises without utilization evidence.
• Treat the 2027 spectrum close and Starship launch plans as contingent, longer-dated catalysts. Track regulatory approvals and flight cadence rather than capitalizing planned capacity as current earnings.
• Monitor AI-credit spreads and issuer-specific financing terms as a cross-check, not as a standalone short signal. A wider funding premium alongside weaker backlog conversion would strengthen the cautious thesis; improving terms and execution would falsify it.